Armed with a new $10 million grant, a multi-center “dream team’’ of scientists, led by UCSF, is embarking on a groundbreaking undertaking to overcome therapeutic resistance and revolutionize treatment for patients with advanced prostate cancer.
Scientists at the UCSF-affiliated Gladstone Institutes have mapped the precise frequency by which genes get turned on across the human genome, providing new insight into the most fundamental of cellular processes — and revealing new clues as to what happens when this process goes awry.
Scientists at the UCSF-affiliated Gladstone Institutes have discovered how a protein deficiency may be linked to frontotemporal dementia (FTD) — a form of early-onset dementia similar to Alzheimer’s disease. These results lay the foundation for therapies that one day may benefit those who suffer from this and related brain diseases.